Support for a major IDD research center focused on improving lives of children with developmental disabilities
Official title: Support for the Rose F. Kennedy IDDRC P50
Funded at Albert Einstein College of Medicine · NIH-11522001 · Data updated 2026-11-12
A large NIH grant supports a leading IDD center at Albert Einstein College of Medicine to advance basic, translational, and clinical work helping children with intellectual and developmental disabilities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | June 25, 2026 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $999,891 |
| NIH project number | 3P50HD105352-05S1 |
| Project ID | NIH-11522001 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children and families affected by intellectual and developmental disabilities who may participate through the Human Clinical Phenotyping Core or related research activities.
✕Less likely to help
Some participants may not directly benefit from the research during the project period, depending on study participation and outcomes.
What this research studies
This grant funds a comprehensive research center that brings together clinical phenotyping, neurogenomics, neural cell engineering, and animal phenotyping to study IDDs in children. The center provides core facilities and experienced faculty to accelerate research that could translate into better understanding and care for kids with developmental disabilities. By connecting human studies with animal and cellular models, the project aims to map how biology shapes development and behavior in IDDs. Families and patients may benefit from faster access to cutting-edge tools and opportunities to participate in research through coordinated cores.
Why it matters
Potential benefit: If successful, this center could speed the discovery of mechanisms and potential therapies for intellectual and developmental disabilities in children.
How similar studies have gone: IDDRCs have historically advanced understanding and translational progress in IDDs, with ongoing improvements in tools and collaborations.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Molholm, Sophie — Albert Einstein College of Medicine
- Study coordinator: Molholm, Sophie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.